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Angiotensinogen gene null-mutant mice lack homeostatic regulation of
glomerular filtration and tubular reabsorption. Chronic volume depletion
by dietary salt restriction causes marked decrease in glomerular filtration
rate (GFR) with little increase in urine osmolality in angiotensinogen gene
null mutant (Agt2/2) mice. Moreover, urine osmolality is insensitive to
both water and vasopressin challenge. In contrast, in normal wild-type
(Agt1/1) mice, GFR remains remarkably constant and urine osmolality is
adjusted promptly. Changes in volume status also cause striking diver-
gence in renal structure between Agt2/2 and Agt1/1 mice. Thus, in contrast
to the remarkably stable glomerular size of Agt1/1 mice, glomeruli of
Agt2/2 mice are atrophied during a low salt and hypertrophied during a
high salt diet. Moreover, the renal papilla, a structure unique to mammals
and essential for urine diluting and concentrating mechanisms, is hypo-
plastic in Agt2/2 mice. Thus, angiotensin is essential for the two funda-
mental homeostatic functions of the mammalian kidney, namely stable
GFR and high urine diluting and concentrating capacity during alteration
in extracellular fluid (ECF) volume. This is not only accompanied by
angiotensin’s tonic effects on renal vasomotor tone and tubule transport-
ers, but also accomplished through its capacity to affect the structure of
both the glomerulus and the papilla directly or indirectly.
The kidney of mammals is characterized by high regulatory
capacity of tubules to reabsorb water while maintaining remark-
ably constant glomerular filtration rate (GFR). Teleologically, the
former is believed to reflect the inconstant availability of drinking
water in mammalian life. In contrast to mammals, many non-
mammalian vertebrate species have highly labile GFR. In these
species, GFR serves primarily as an extracellular fluid (ECF)
volume regulator [1]. Thus, an acute perturbation in volume will
modulate glomerular perfusion, while chronic perturbation will
stimulate adjustments in glomerular size. Indeed, euryhaline fish
adjust their glomerular size when they migrate between sea and
fresh water [2]. Of note, non-mammalian vertebrates can afford to
have highly labile GFR since toxic nitrogenous wastes are elimi-
nated through circulatory systems independently of glomerular
circulation, such as renal tubules and gills. By contrast, in mam-
mals, nitrogenous wastes are eliminated nearly entirely through
the glomerulus. Therefore, mammals, unlike other vertebrates,
must maintain a constant GFR regardless of ECF volume status in
order to rid the body of toxic wastes.
Angiotensin (Ang) II contributes to these features of mamma-
lian kidneys through its constrictive action on renal arterioles
[3–5] and its regulatory effect on ion transports [6–8]. With
regard to the efferent arteriolar constrictive action of angiotensin
II, Guyton wrote, “. . . this provides a means for conserving water
and ions despite the fact that urea continues to be excreted. . . ”
[9]. Apart from this classic view of angiotensin action, recent
studies indicate that angiotensin may promote hypertrophy and
proliferation of some renal cells [10–12].
Most recent DNA recombinant studies [13–18] have demon-
strated that angiotensin is involved in the ontogeny of renal
papilla, a structure unique to mammals and essential for their
characteristically high water reabsorptive capacity. Thus, mutant
mice homozygous for the null mutation of angiotensinogen were
found to have severely hypoplastic papilla. These animals are now
shown by the present study to have urine dilution and concentra-
tion defects during experimental ECF volume expansion and
depletion, respectively. Clearly, therefore, Ang II promotes fluid
reabsorption in mammalian kidneys in part through its papilla
development promoting effect.
Given the importance of Ang II in maintaining GFR in
mammals [19, 20], the present study also tested the possibility that
Ang II may exert another unique function in mammalian kidneys,
namely, to protect glomeruli from changing size during variation
in ECF volume, which occurs in non-mammalian kidneys [21].
The present study, indeed, found that Ang II maintains glomer-
ular size in mammals by abrogating the powerful influence of
extracellular fluid volume on glomerular structure. This preserva-
tion of glomerular size enables mammals to effectively remove,
entirely through the glomerulus, the large amounts of nitrogenous
wastes that are constantly produced independent of their hydra-
tion status.
METHODS
Mice
Wild-type mice and angiotensinogen deletion homozygous lit-
termates were used in this study. These are the offspring of the
angiotensinogen deletion mutants generated earlier by gene tar-
geting in our laboratory [15].
The mice used in the present study were genotyped by Southern
blot analysis of tail DNA. Three micrograms of tail DNA were
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digested with both XbaI and XhoI, and hybridized with a 32P-
labeled 0.7 kb BglII-PstI fragment of the angiotensinogen genomic
DNA (59 flanking probe), which was external to the 59 end of the
targeting vector. F5 mice homozygous for angiotensinogen gene
null mutation (Agt2/2) and wild-type (Agt1/1) littermates were
subjected to the analyses described below. Heterozygous litter-
mates were not studied.
Dietary regimens
Mice were fed either a high sodium (HS) purified diet (3.15%
Na; Purina Mills, Inc., St. Louis, MO, USA), low sodium (LS)
purified diet (0.02% Na), or normal mouse chow [normal sodium
(NS), 0.46% Na] for two weeks beginning at the time of weaning
(Fig. 1). All animals had free access to food and tap water.
Blood pressure measurement
Mice (5 weeks old) were anesthetized with an intraperitoneal
injection of pentobarbital (Nembutal; 50 mg/kg body wt i.p.;
Abbott Laboratories., North Chicago, IL, USA) and placed on a
temperature-controlled warm table. PE10 tubing, heated and
tapered at one end, filled with a heparin (100 U/ml)-saline
solution was inserted into the left carotid artery. The remaining
portion was threaded under the skin and exited at the nape, where
the end of the cannula was sealed by heating. Twenty-four hours
after surgery, a piece of PE50 tubing was connected to the carotid
artery cannula. The other end of the tubing was connected to a
swivel to allow free mobility of the mouse. Blood pressure was
measured in these conscious mice with a Cobe CDX III trans-
ducer which was connected to a Blood Pressure Analyzer (Micro-
Med, Inc., Louisville, KY, USA). Blood pressure and heart rate
were continuously monitored for 30 to 60 minutes until they
became stable in a quiet and unrestrained environment.
Assessment of kidney function
Urine and plasma osmolality and plasma creatinine. Mice (5
weeks old) were kept in a metabolic cage (Metabolica Type
MC-ST; SGI, Tokyo, Japan) for three days and urine was col-
lected during the last 24 hours. Blood samples were then col-
lected, and water consumption measured. Osmolality of urine and
plasma was measured with an Osmette Model 5004 (Precision
Systems, Inc., Sudbury, MA, USA). Plasma creatinine concentra-
tion was measured with Creatinine Analyzer 2 (Beckman Instru-
ments, Inc., Fullerton, CA, USA).
Inulin clearance. Mice (5 weeks old) were anesthetized with an
intraperitoneal injection of inactin (100 mg/kg body wt i.p.; BYK,
Konstanz Germany). The PE10 tubing (Becton Dickinson and
Company, Sparks, MD, USA), heated and tapered at one end,
filled with heparin (100 U/ml)-saline solution, was inserted into
the left carotid artery and jugular vein for blood sampling and
injection of inulin. On completion of surgery, 0.1 ml of mouse
plasma was infused over 10 minutes, followed by constant infusion
of 4.75% inulin (USP; Iso-Tex Diagnostics., Friendswood, TX,
USA) in normal saline at 0.254 ml/hr. After 60 minutes of
equilibration time, three consecutive 15-minute urine collections
were made. A blood sample was taken at the end of the first and
third collection. Inulin concentration was measured with a stan-
dard anthrone method [22]. The renal clearance rate of inulin was
calculated from a standard equation of clearance. The plasma
inulin concentration of first sample, mean of first and second
samples, and second sample were used for the calculation of first,
second and third determination of the inulin clearance rate,
respectively.
Effect of water challenge and DDAVP on urine osmolality.
Protocol of this experiment was shown in Figure 2. Prior to study,
the mice (5 to 6 weeks old) were maintained on normal mouse
chow. For the purpose of diuresis, 5% dextrose in distilled water
was given to these mice as drinking water for two days before the
experiment. Mice were anesthetized with an intraperitoneal injec-
tion of inactin (100 mg/kg body wt i.p.; BYK) and placed on a
temperature-controlled warm table. PE10 tubing (Becton Dickin-
son), heated and tapered at one end, filled with heparin (100
U/ml)-saline solution, was inserted into the left jugular vein for
infusion. In order to maintain hyposthenuria during the experi-
ment, the mice were given an infusion of hypotonic dextrose-NaCl
Fig. 1. The protocol for dietary regimens used
in the present study. Wild-type (Agt1/1) and
homozygous angiotensinogen deletion mutant
(Agt2/2) mice were obtained by mating
heterozygous (Agt1/2) males and females. After
weaning and genotying at three weeks, both
Agt1/1 and Agt2/2 mice were fed either high,
normal or low sodium-containing diets for two
weeks. At the age of five weeks, they were
subjected to the studies.
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solution (0.83% dextrose, 0.3% NaCl) at the rate of 60 ml/kg/hr
for two to three hours, which maintained urine osmolality at less
than 172 mOsm/kg H2O in Agt
1/1 mice. The infusion rate was
then reduced to 40 ml/kg/hr for the remainder of the water
diuresis period of study. One hour after the decrease of infusion
speed, DDAVP (1 mg/kg bolus i.v., deamino-Cys1, D-Arg8 vaso-
pressin; Sigma Chemical Co., St. Louis, MO, USA) was injected.
Urine was collected every 15 minutes from the beginning of
infusion until three hours after the injection of DDAVP. In
Agt1/1 mice, urine osmolality reached maximum value (more than
1000 mOsm/kg H2O) usually one to two hours after DDAVP
injection.
Light microscopic study
Kidneys were fixed in 4% buffered paraformaldehyde for 24
hours, embedded in paraffin, coronally sectioned in a thickness of
3 mm including papilla, and stained with periodic acid-Schiff. The
average glomerular tuft area of all glomeruli present in the section
was measured planimetrically using the Micro-Plan IITM image
analysis system (Donsanto, Natick, MA, USA). All the morpho-
logical analyses were obtained by an independent pathologist
without any information about the genotype of mice from which
specimens were harvested.
Immunohistochemistry for a-smooth muscle actin and
proliferative cell nuclear antigen
Kidneys from mice on three different diet regimens were
stained for a-smooth muscle actin and proliferative cell nuclear
antigen (PCNA). Horseradish peroxidase-coupled mouse anti-
human a-smooth muscle actin antibody and mouse anti-human
PCNA antibody (DAKO, Glostrup, Denmark) and stable DAB (a
reagent with diaminobenzidine and hydrogen peroxide; Research
Genetics, Inc., Huntsville, AL, USA) were used for staining.
In situ hybridization study for TGF-b1
Mouse transforming growth factor-beta1 (TGF-b1) cDNA
clone (gift from Dr. H. Moses, Vanderbilt Medical School,
Nashville, TN, USA) was used as a template to synthesize
35S-labeled antisense and sense cRNA probe. These probes cover
1.0 kb (421-1395 bp) of mouse TGF-b1 cDNA. The protocol for
in situ hybridization used in the current study is essentially
identical to that used previously [23, 24]. Briefly, the 3-mm tissue
sections were treated with 20 mg/ml proteinase K and acetic
anhydride successively, dehydrated in 30 to 100% ethanol and
air-dried. Sixty milliliters of hybridization mixture containing 2 3
104 cpm/ml of 35S-labeled cRNA probe, 50% deionized form-
amide, 10% dextran sulfate, 8 mM DTT, 0.2 mg/ml tRNA and 1 3
salts (300 mM NaCl, 10 mM Tris-HCl, 5 mM EDTA, 0.02%
polyvinylpyrolidone, 0.02% Ficoll, and 0.02% BSA) were overlaid
on the specimens and incubated for 15 hours at 50°C in a
humidified chamber. The specimens were washed in 50% deion-
ized formamide, 2 3 SSC, 100 mM DTT at 65°C for 20 minutes,
followed by 20 mg/ml RNase at 37°C for 30 minutes. They were
further washed in 2 3 SSC, followed by 0.1 3 SSC at 65°C,
dehydrated in 30 to 100% ethanol with 0.3 M ammonium acetate,
and air-dried. The slides were dipped in photographic emulsion
(Ilford K-5 emulsion; Ilford Ltd., Essex, UK) and exposed at 4°C
for 7 to 10 days. The sections were developed with D-19 developer
(Eastman Kodak Co., Rochester, NY, USA) and counter-stained
with 0.02% toluidine blue.
Plasma atrial natriuretic factor level
In order to confirm the comparably decreased state of extra-
cellular fluid volume during low sodium diet, plasma atrial
natriuretic factor (ANF) was measured in Agt1/1 and Agt2/2 mice
on low sodium diet. Mice were decapitated and truncal blood was
collected promptly into tubes kept on ice in the presence of
EDTA (10 mM). The plasma was rapidly separated and kept
frozen at 270°C until measurement. A commercial radioimmu-
noassay (RIA) (RIK9103; Peninsula Labs, Inc., Belmont, CA,
USA) was used to analyze the concentration of irANF protein.
Plasma irANF was measured directly on 25 ml plasma.
Statistical analysis
Data are presented as mean 6 SEM. Statistical significance was
assessed by analyzing variance, unpaired t-test and Mann-Whitney
test, following ANOVA.
RESULTS
Glomerular function
As shown in Table 1, plasma creatinine concentration averaged
0.20 mg/dl 6 0.00 in Agt1/1 mice on normal sodium diet. Value
was unaffected during low sodium diet, but was slightly lower
during high sodium diet. When compared to these values, those
obtained in Agt2/2 mice were some twofold higher during all
three dietary regimens. Within Agt2/2 mice, plasma creatinine
level was higher during low and normal than high sodium diet, and
during low than normal sodium diet.
Results of inulin clearance measurements echo these results of
plasma creatinine levels. Thus, whereas values were largely unaf-
fected by dietary sodium regimens in Agt1/1 mice (Fig. 3, 1.17 6
0.05 ml/min/100 g body wt, 1.04 6 0.03, 0.97 6 0.05 during high,
normal and low sodium diets, respectively), high sodium (P . 0.1)
increased, and low sodium (P . 0.1) decreased, inulin clearance
in Agt2/2 mice when compared to values during normal sodium
diet (0.53 6 0.07 ml/min/100 g body wt, 0.32 6 0.08, 0.18 6 0.05
during respective diets, N 5 4 each group).
Fig. 2. Anesthetized mice, after catheterization of the left jugular vein,
were given an infusion of hypotonic dextrose-NaCl solution (0.83%
dextrose, 0.3% NaCl) at the rate of 60 ml/kg/hr for two to three hours.
Infusion rate was then reduced to 40 ml/kg/hr for the remainder of the first
study period. At the end of the first period, one hour after reduction of i.v.
infusion rate, DDAVP (1 mg/kg bolus i.v., deamino-Cys1, D-Arg8 vaso-
pressin) was given intravenously. Urine was collected every 15 minutes
from the onset of hypotonic fluid infusion till three hours after the
injection of DDAVP.
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Urine diluting and concentrating capacity
Urine flow rate was higher in Agt2/2 than Agt1/1 mice during
all three diets (Table 1, N 5 3 each group). Of note, in Agt1/1
mice, the urine flow rate was significantly lower during low sodium
diet when compared to that during normal (P , 0.05) or high
sodium diet (P , 0.05). By contrast, no significant difference was
observed among the three diets in Agt2/2 mice. This tendency was
duplicated in water intake (Table 1). Water intake was substan-
tially higher in Agt2/2 than Agt1/1 mice for all three diets (N 5 3
each group).
Urine osmolality was lower in Agt2/2 mice when compared to
that in Agt1/1 mice (Fig. 4A), averaging 1427 6 223 mOsm/kg
H2O, 1509 6 158 and 3068 6 152 during the high, normal and low
sodium diets, respectively, in Agt1/1 mice; and 934 6 43, 644 6 45
and 612 6 46 on the high, normal and low sodium diets,
respectively, in Agt2/2 mice (N 5 3 each group). The difference
between Agt1/1 and Agt2/2 mice was statistically significant for
normal and low sodium diet. Moreover, in Agt1/1 mice, urine
osmolality was higher during low sodium diet when compared to
that during normal or high sodium diet. Contrastingly, in Agt2/2
mice, urine osmolality during low sodium diet was not different
from that during normal sodium diet, and, in fact, was lower than
that during high sodium diet. The pattern, if any, seen in plasma
osmolality was opposite to that of urine osmolality. Thus, plasma
osmolality was often higher in Agt2/2 mice than in Agt1/1 mice
(Fig. 4B; 308 6 5 mOsm/kg H2O, 326 6 5 and 325 6 1 during
high, normal and low sodium diets, respectively, in Agt1/1 mice;
and 325 6 8, 340 6 1 and 382 6 14 during high, normal and low
sodium diets, respectively, in Agt2/2 mice. N 5 3 each group).
The response of urine osmolality to infusion of hypotonic
solution and injection of DDAVP is shown in Figure 5. The
minimum urine osmolality before the injection of DDAVP was
lower in Agt1/1 mice than Agt2/2 mice (103 6 17 mOsm/kg H2O
and 245 6 47, P , 0.05, N 5 6 each groups) and maximum
osmolality after DDAVP injection was higher in Agt1/1 mice than
Agt2/2 mice (1203 6 89 and 432 6 41, P , 0.0001, N 5 6 in each
group). The degree of increase in urine osmolality after DDAVP
injection was higher in Agt1/1 mice than Agt2/2 mice (11.7 times
and 1.8 times, respectively; P , 0.001). Continuous injection of
hypotonic dextrose-NaCl solution at the rate of 60 ml/kg/hr for
more than three hours caused uniform death in three Agt2/2 mice
with no more decrease in urine osmolality.
Glomerular morphology
Typical microscopic patterns seen in the superficial cortex of
animals of all groups are shown in Figure 6. As shown, in Agt1/1
mice, the size of glomeruli was not affected by dietary regimens.
By contrast, in Agt2/2 mice, the glomerular size was significantly
increased during high sodium diet and decreased during low
sodium diet when compared to that during normal sodium diet.
As shown in Figure 7, the mean glomerular tuft area averaged
1.95 6 0.08 mm3 (N 5 5), 2.01 6 0.11 (N 5 5) and 1.98 6 0.09
(N 5 5) during high, normal and low sodium diets, respectively, in
Agt1/1 mice; and 2.24 6 0.15 (N 5 5), 1.47 6 0.09 (N 5 5) and
1.06 6 0.02 (N 5 5) on high, normal and low Na diets, respec-
tively, in Agt2/2 mice. The difference between Agt1/1 and Agt2/2
mice was statistically significant for the normal and low sodium
diets. The results of in situ hybridization for TGF-b1 and immu-
nohistochemistry for a-smooth muscle actin and PCNA are shown
in Figure 8. The findings of Agt1/1 mice on high and low sodium
diet were the same as normal sodium diet (not shown). The
expression of mRNA of TGFb1 was not detected in the glomeruli
of both Agt1/1 and Agt2/2 mice on any of the three different diet
regimens. The proportions of glomeruli that showed positive
staining of a-smooth muscle actin in mesangial area on high,
Table 1. Mean arterial pressure, water intake and whole kidney functions in Agt1/1 and Agt2/2 mice placed on a high, normal or low sodium-
containing diet
Agt1/1 Agt2/2
High Na Normal Na Low Na High Na Normal Na Low Na
Urine flow rate ml/24 hr/100 g body wt 18.3 6 3.2 13.1 6 2.8 4.1 6 1.3a,b 32.2 6 4.4 28.2 6 2.2c 24.3 6 1.6c
Water intake ml/24 hr/100 g body wt 25.2 6 5.0 15.6 6 0.3 9.8 6 2.6 39.0 6 7.5 42.9 6 2.2c 33.1 6 2.7b,c
Plasma creatinine mg/dl 0.13 6 0.03 0.20 6 0.00 0.20 6 0.00 0.20 6 0.00 0.30 6 0.00a,c 0.43 6 0.07b,c
Mean arterial blood pressure mm Hg 107 6 2 105 6 2 107 6 1 80 6 4c 70 6 3c 54 6 4a,b,c
The values are given as mean 6 SEM (N 5 3 mice for each parameter). Statistically significant (P , 0.05) compared to that of the same genotype,
on high Na (a) or normal Na (b), or to that of Agt1/1 mice on the same diet (c) by t-test (urine flow rate, water intake and mean arterial blood pressure)
or by Mann-Whitney test (plasma creatinine).
Fig. 3. Inulin clearance rate in wild-type (Agt1/1, f) and homozygous
angiotensinogen deletion mutant (Agt2/2, M) mice placed on three
different dietary sodium regimens. Values were largely unaffected by
dietary sodium in Agt1/1 mice (1.17 6 0.05 ml/min/100 g body wt, 1.04 6
0.03 and 0.97 6 0.05 during high, normal and low sodium diets, respec-
tively). In Agt2/2 mice, however, high sodium (P . 0.1) increased and low
sodium (P . 0.1) decreased inulin clearance rate when compared to
normal sodium diet (0.53 6 0.07 ml/min/100 g body wt, 0.32 6 0.08, and
0.18 6 0.05 during their respective diets, N 5 4 each group). Values are
given as mean 6 1 SE.
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normal and low sodium diets were 1.5 6 1.0%, 1.8 6 0.5 and 1.9 6
0.5 (N 5 3, each group), respectively in Agt1/1 mice, and there
was no statistically significant difference among the groups. In
Agt2/2 mice, these proportions on the high, normal and low
sodium diets were 22.0 6 2.3%, 14.7 6 3.9 and 4.1 6 1.0 (N 5 3,
each group) respectively, and significantly higher compared to
those of Agt1/1 mice on the high and normal diets (P , 0.005, P ,
0.05, respectively). In Agt2/2 mice, this proportion was signifi-
cantly higher on high sodium diet compared to low sodium diet
(P , 0.001). The proportions of glomeruli that contained PCNA
positive nuclei on the high, normal and low sodium diets were
1.1 6 0.6%, 0.7 6 0.3 and 1.2 6 0.6 (N 5 3, each group)
respectively in Agt1/1 mice, and there was no statistically signifi-
cant difference among the groups. In Agt2/2 mice, these propor-
tions on the high, normal and low sodium diets were 5.2 6 0.8%,
6.0 6 0.4 and 2.4 6 0.7 (N 5 3, each group), respectively, and
significantly higher compared to those of the Agt1/1 mice on a
high sodium diet (P , 0.05). In Agt2/2 mice, this proportion was
significantly higher on the normal sodium diet compared to low
sodium diet (P , 0.01).
Papillary morphology
In five-week-old Agt2/2 mice, the pelvic space was enlarged and
the papilla was uniformly hypoplastic (or atrophic) (Fig. 9). These
patterns essentially duplicate those reported by us earlier from
three week old Agt2/2 mice [15].
Systemic blood pressure
Values for mean systemic arterial pressure are shown in Table
1 (N 5 3, N 5 4 and N 5 3 for high, normal and low sodium diets,
respectively, in Agt1/1 mice; and N 5 3 for all diets in Agt2/2
mice). Values were unaffected by dietary sodium content in
Agt1/1 mice, whereas all Agt2/2 mice were hypotensive and the
level of blood pressure had a direct relationship with dietary
sodium content (P , 0.005, P , 0.0005 and P , 0.0005 during
high, normal and low sodium diets, respectively). In Agt2/2 mice,
mean blood pressure was lower during low sodium diet when
compared to that during high (P , 0.01) or normal sodium diet
(P , 0.05).
Plasma atrial natriuretic factor level
Plasma ANF concentration was determined after 14 days of the
low sodium dietary regimen. Plasma ANF concentration was
8.2 6 0.5 pg/100 ml (N 5 4) in Agt1/1 mice and 11.2 6 1.3 (N 5
5) in Agt2/2 mice. There was no statistically significant difference
(P . 0.05).
Fig. 4. Urine osmolality of wild-type (Agt1/1, f) and homozygous angio-
tensinogen deletion mutant (Agt2/2, M) mice placed on three different
dietary sodium regimens (A). Urine osmolality was lower in Agt2/2 mice
when compared to that in Agt1/1 mice during high, normal and low
sodium diets. Plasma osmolality of these Agt1/1 and Agt2/2 mice on
different sodium diets (B). Plasma osmolality was often higher in Agt-/-
mice than in Agt1/1 mice (308 6 5 mOsm/kg H2O, 326 6 5 and 325 6 1
during the high, normal and low sodium diets, respectively, in Agt1/1 mice;
and 325 6 8, 340 6 1 and 382 6 14 during the high, normal and low
sodium diets, respectively, in Agt2/2 mice. N 5 3 each group). Values are
given as mean 6 1 SE.
Fig. 5. Water challenge and DDAVP tests in Agt1/1 mice (f) and Agt2/2
mice (M). The minimum urine osmolality achieved by i.v. hypotonic fluid
infusion before the injection of DDAVP was significantly lower in Agt1/1
mice than Agt2/2 mice (103 6 17 mOsm/kg H2O and 245 6 47, P , 0.05,
N 5 6 each group), and the maximum osmolality after DDAVP injection
was significantly higher in Agt1/1 mice than Agt2/2 mice (1203 6 89 and
432 6 41, P , 0.0001, N 5 6 each group). Values are given as mean 6 1
SE.
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DISCUSSION
In the present study we found that Agt2/2 mice have severely
limited capacity for both urinary dilution and concentration. Thus,
during water challenge, whereas urine osmolality fell to ;100
mOsm/kg H2O in wild-type mice, that of Agt
2/2 mice remained at
;250 mOsm/kg H2O, or near-isotonic. In addition, a maximal
dose of the vasopressin analog, DDAVP, led to an increase in
urine osmolality to ;1,200 mOsm/kg H2O in wild-type mice,
whereas the urine osmolality of Agt2/2 mice increased only
slightly to ;400 mOsm/kg H2O. Not surprisingly, therefore,
during chronic ECF volume depletion with low Na diet, urine
osmolality decreased (instead of increased!) to ;600 mOsm in
Agt2/2 mice, a level only ;1/5 of that achieved in Agt1/1 mice
(Fig. 4A), and ;2/3 of Agt2/2 mice on the high Na diet. Given the
notion that normal mammals undergoing severe ECF volume
depletion, hypotension and ‘prerenal’ failure with accompanying
fall in GFR concentrate their urine maximally, the observed urine
concentration defect (or paradoxical fall in urine osmolality) in
Agt2/2 mice must be attributed to a mechanism that is ‘intrinsi-
cally renal’ in nature. These findings echo the recent observations
by Esther et al [17] in mice homozygous for angiotensin I
converting enzyme gene null mutation, that is, their mutants had
a similar hyposthenuria. The hyposthenuria was seen in Agt2/2
mice despite a plasma osmolality level substantially higher than
that of Agt1/1, a pattern typical for diabetes insipidus (Fig. 4B).
Fig. 6. Typical glomerular morphology in Agt1/1 (top) and (Agt2/2) mice (bottom) after two weeks of high (left), normal (center) or low (right) sodium
diet regimen. The size of glomerulus was not affected by any of the diets in Agt1/1 mice. In contrast, the glomerulus from Agt2/2 mice placed on high
sodium diet increased in size, whereas that of Agt2/2 mice on low sodium diet decreased (Periodic acid Schiff stain, 3400).
Fig. 7. Mean glomerular tuft area measured in wild-type (Agt1/1, f) and
homozygous angiotensinogen deletion mutant (Agt2/2, M) mice placed on
three different dietary sodium regimens. The mean glomerular tuft area
averaged 1.95 6 0.08 mm3 (N 5 5), 2.01 6 0.11 (N 5 5) and 1.98 6 0.09
(N 5 5) during high, normal and low sodium diet, respectively, in Agt1/1
mice; and 2.24 6 0.15 (N 5 5), 1.47 6 0.09 (N 5 5) and 1.06 6 0.02 (N 5
5) on high, normal and low Na diet, respectively, in Agt2/2 mice. The
difference between Agt1/1 and Agt2/2 mice was significant for the normal
and low diets. Values are given as mean 6 1 SE.
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The polydipsia present in Agt2/2 mice (Table 1) is, therefore,
taken to represent, at least in part, an adaptive mechanism
secondary to this urine concentration defect. Since a maximal
dose of AVP failed to substantially increase the urine osmolality
of Agt2/2 mice, the urine concentrating defect of these mice is
attributed to an impaired responsiveness of the kidney to AVP
rather than to an impaired secretory process of AVP. Of note, our
present studies found that the unresponsiveness to AVP, hence
impaired free water reabsorption, is accompanied by a defect in
free water generation, indicating a presence of broader derange-
ments in the counter-current system of the kidney, involving not
only deep cortical but also superficial nephrons. These concurrent
abnormalities at the functional level are well in concert with the
abnormal morphological pattern found in Agt2/2, specifically,
hypoplastic papilla as reported earlier by us [15] and duplicated in
the present study. Clearly, angiotensin is essential for the formu-
lation of papilla, a structure unique to mammals, which enables
them to regulate free water generation and reabsorption, func-
tions essential for the volume and osmolality homeostasis of the
body fluid.
The kidney of Agt2/2 mice was found in our study to structur-
ally and functionally resemble non-mammalian kidneys in another
major way. Thus, in response to chronic manipulation of dietary
salt intake, whole kidney glomerular filtration rate (GFR) esti-
mated by plasma creatinine level during an awake condition and
by inulin clearance measurement during anesthetized condition
changed markedly in Agt2/2 mice, contrasting to the GFR of
Agt1/1 mice. In the latter, GFR is, as demonstrated in the present
study, characteristically insensitive to chronic manipulation of
ECF volume [25, 26]. Our study further revealed that the ECF
volume-sensitive GFR found in Agt2/2 mice is accompanied by
two contributory phenomena: variability in perfusion pressure and
Fig. 8. Immunohistochemical studies for a-smooth muscle actin (a-SMA, brown in color) and proliferative cell nuclear antigen (PCNA, brown in
color) and in situ hybridization studies for transforming growth factor-b1 (TGF-b1) mRNA (dark fine grains) on glomeruli from Agt1/1 and Agt2/2
mice fed a high, normal or low sodium-containing diet. Results from Agt-1/1mice on high or low sodium diet are not shown as those are indistinguishable
from those of Agt1/1 mice on normal sodium diet. a-SMA positive staining within the glomerulus was more discernible in Agt2/2 mice when they were
placed on high and normal sodium diet in comparison to that on low sodium diet. PCNA positive nuclei within the glomerulus were more abundant
in Agt2/2 mice on high and normal sodium diets than on a low sodium diet. The mRNA of TGF-b1 was undetectable in the glomerulus of both Agt1/1
and Agt2/2 mice regardless of dietary regimen employed (3200).
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changes in glomerular size. Thus, in Agt2/2 mice, renal perfusion
pressure as reflected by systemic arterial pressure was found in
our study to be highly sensitive to dietary sodium intake (Table 1).
Such changes in renal perfusion pressure lead to parallel changes
in GFR in the absence of adjustments of vasomotor tone within
the glomerular microcirculation, which involves the constrictor
action of Ang II [20]. Attenuation of the tubuloglomerular
feedback may also contribute to the labile GFR, since the
feedback is essential for the constancy of GFR during reduced
renal perfusion pressure, and the feedback is inefficient in the
absence of intact renin-angiotensin system [27]. Most remarkably,
the size of glomeruli in Agt2/2 mice was found to directly change
proportionally to the amount of dietary sodium intake, although
currently no technology is available to quantitate the relative
importance of all these potential mechanisms for the highly ECF
volume-sensitive GFR in Agt2/2 mice. As PCNA positivity was
significantly increased during high sodium diet only in Agt2/2
mice, the increase in glomerular size in these mutants given high
sodium involves cell hyperplasia. Given the expanded a-smooth
muscle actin-positive area within the glomerulus of the latter, the
increase in glomerular size is attributed in part, if not entirely, to
mesangial cell proliferation. However, activation of TGF-b1, a
well known mesangial growth factor, does not account for the
proliferation, as the expression of this growth factor was not
detected in any of the conditions tested. It is probable that other
unmeasured growth factors, such as PDGF [28], basic FGF [29],
or IGF-1 [30] are involved in the observed mesangial cell prolif-
eration.
Overall, the functional pattern of the kidney of Agt2/2 mice is
clearly abnormal, that is, labile GFR and lack of urine concen-
trating capacity during changes in ECF volume. Thus, the kidney
of Agt2/2 mice has lost its fundamental homeostatic functions,
that of constant elimination of nitrogeneous wastes and preserva-
tion of ECF volume. Moreover, such a loss of functional charac-
teristics of mammalian kidneys in Agt2/2 mice is accompanied by
a loss of structural characteristics of mammalian kidneys; namely,
the papilla is hypoplastic and the dimension of glomeruli now
varies in accordance with the status of hydration. These observed
functional and structural defects of Agt2/2 mice are taken to
reflect the renal actions of Ang II that are unique to mammals.
During evolution from lower to higher vertebral species, angio-
tensin is believed to have progressively recruited several organs as
its target tissues. These recruitments are all geared toward
imparting to the animal efficient measures to meet the altered
metabolic need from their new environment. It is speculated that,
during evolution, angiotensin enabled the animal to progressively
gain the ability to retain fluid, first through controlling glomerular
perfusion and, shortly thereafter, through stimulating fluid intake
via receptors in the brain. Subsequently, by stimulating tubule
fluid reabsorption, either directly or through aldosterone, angio-
tensin further promoted fluid conservation. The results of our
studies on Agt2/2 mice indicate that, in mammals, angiotensin has
recruited fourth and fifth targets, namely, the glomerulus and the
papilla. These two targets are crucial for mammalian life, as they
must constantly eliminate nitrogen wastes entirely through the
glomerulus while preserving their hydration status, despite the
highly variable availability of water in their environment.
In conclusion, while the present study provides unequivocal
evidence for the dual roles of angiotensin to preserve stable GFR
and to achieve a high regulatory capacity for water reabsorption
[9], the study further reveals that such roles of Ang II are unique
Fig. 9. Coronal sections of kidneys from five-week-old Agt1/1 and Agt2/2 mice. Pelvic dilation was present in Agt2/2 mice with atrophic (or hypoplastic)
papilla, contrasting to the normal appearing kidney from Agt1/1 mice. (Periodic acid Schiff stain, 310).
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to mammals and that both structure and function of the glomer-
ulus and papilla are direct or indirect targets of Ang II.
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